Thomas J. Lynch Jr. - 27 Oct 2022 Form 3 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol
FHTX
Transactions as of
27 Oct 2022
Net transactions value
$0
Form type
3
Filing time
31 Oct 2022, 16:01:49 UTC
Next filing
22 Jun 2023

No securities are beneficially owned.